Determination of ambroxol of bromhexine in pharmaceuticals by capillary isotachophoresis

Citation
M. Pospisilova et al., Determination of ambroxol of bromhexine in pharmaceuticals by capillary isotachophoresis, J PHARM B, 24(3), 2001, pp. 421-428
Citations number
25
Categorie Soggetti
Chemistry & Analysis
Journal title
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
ISSN journal
07317085 → ACNP
Volume
24
Issue
3
Year of publication
2001
Pages
421 - 428
Database
ISI
SICI code
0731-7085(200101)24:3<421:DOAOBI>2.0.ZU;2-K
Abstract
Expectorant drugs ambroxol (AX) and bromhexine (BX) were determined by capi llary isotachophoresis (ITP) with conductimetric detection. The leading ele ctrolyte (LE) was a buffer solution that contained 5 mM picolinic acid and 5 mM potassium picolinate (pH 5.2). The terminating electrolyte (TE) was 10 mM formic acid. The driving current was 80 muA (for approximate to 200 s) or 50 muA (for approximate to 350 s) and the detection current was 20 muA ( a single analysis took about 8 min). The effective mobilities of AX and EX (evaluated with tetraethylammonium as the mobility standard) were 18.8 x 10 (-9) m(2) V-1 s(-1) and 14.3 x 10(-9) m(2) V-1 s(-1) respectively. The cali bration graphs relating the ITP zone length to the concentration of the ana lytes were rectilinear (r = 0.9993-0.9999) in the range 10 mg l(-1) (20 mg l(-1) for EX) to 200 mg l(-1) of the drug standard. The relative standard d eviations (RSD) were 1.2-1.6% (n = 6) when determining 100 mg l(-1) of the analytes in pure test solutions. The method has been applied to the assay o f AX or EX in seven commercial mass-produced pharmaceutical preparations. A ccording to the validation procedure based on the standard addition techniq ue the recoveries were 97.5-102.7% of the drug and the RSD values were 0.11 -2.20 (n = 6). (C) 2001 Elsevier Science B.V. All rights reserved.